Publications
Below you can find a list of our published research.
Below you can find a list of our published research.
6125 results
Cited 1 times since 2022 (0.4 per year) source: EuropePMC
Nutrition, metabolism, and cardiovascular diseases : NMCD, Volume 33, Issue 1, 8 2 2022, Pages 56-64 Development, internal reliability and preliminary construct validity of the Dutch Dietary Intention Evaluation Tool for In-patients (DIETI). de Frel DL, Wicks H, Bakk Z, van Keulen N, van Adrichem V, van Tussenbroek N, Atsma PDE, Janssen VR
Background and aims: Diet is important in prevention and management of non-communicable disease and in particular, cardiovascular disease. Recently, more hospitals gear towards healthier dietary policies, however, a tool to assess the effect of these interventions in patient populations is currently lacking. The Theory of Planned Behavior (TPB) is generally used to assess health-related behavior and offers a framework for development of questionnaires. In this study, we aim to evaluate the relia... Abstract
Cited 11 times since 2022 (4.6 per year) source: EuropePMC
Circulation, Volume 146, Issue 19, 7 1 2022, Pages 1434-1443 Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study. Gasperetti A, Carrick RT, Costa S, Compagnucci P, Bosman LP, Chivulescu M, Tichnell C, Murray B, Tandri H, Tadros R, Rivard L, van den Berg MP, Zeppenfeld K, Wilde AAM, Pompilio G, Carbucicchio C, Dello Russo A, Casella M, Svensson A, Brunckhorst CB, van Tintelen JP, Platonov PG, Haugaa KH, Duru F, Te Riele ASJM, Khairy P, Tondo C, Calkins H, James CA, Saguner AM, Cadrin-Tourigny J
Background: A novel risk calculator based on clinical characteristics and noninvasive tests that predicts the onset of clinical sustained ventricular arrhythmias (VA) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) has been proposed and validated by recent studies. It remains unknown whether programmed ventricular stimulation (PVS) provides additional prognostic value. Methods: All patients with a definite ARVC diagnosis, no history of sustained VAs at diagnosis, and PVS... Abstract
Disability and rehabilitation, Volume 45, Issue 21, 7 1 2022, Pages 3539-3548 Conservative management for lumbar radiculopathy based on the stage of the disorder: a Delphi study. Thoomes E, Falla D, Cleland JA, Fernández-de-Las-Peñas C, Gallina A, de Graaf M
Purpose: Conservative management of lumbar radiculopathy (LR) is the first treatment option. To date, systematic reviews and clinical practice guidelines have not considered the most appropriate timing of management. This study aimed to establish consensus on effective conservative treatment modalities across different stages (i.e., acute, sub-acute, or chronic) of LR. Materials and methods: Through an iterative multistage Delphi process, experts rated agreement with proposed treatment modalitie... Abstract
Cited 3 times since 2022 (1.3 per year) source: EuropePMC
Journal of medical Internet research, Volume 24, Issue 10, 6 1 2022, Pages e38339 Investigating Rewards and Deposit Contract Financial Incentives for Physical Activity Behavior Change Using a Smartphone App: Randomized Controlled Trial. de Buisonjé DR, Reijnders T, Cohen Rodrigues TR, Prabhakaran S, Kowatsch T, Lipman SA, Bijmolt THA, Breeman LD, Janssen VR, Kraaijenhagen RA, Kemps HMC, Evers AWM
Background: Financial incentive interventions for improving physical activity have proven to be effective but costly. Deposit contracts (in which participants pledge their own money) could be an affordable alternative. In addition, deposit contracts may have superior effects by exploiting the power of loss aversion. Previous research has often operationalized deposit contracts through loss framing a financial reward (without requiring a deposit) to mimic the feelings of loss involved in a deposi... Abstract
Cited 4 times since 2022 (1.7 per year) source: EuropePMC
European heart journal. Cardiovascular Imaging, Volume 23, Issue 11, 1 1 2022, Pages 1540-1551 Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial. Namazi F, Delgado V, Delgado V, Pio SM, Ajmone Marsan N, Asch FM, Medvedofsky D, Weissman NJ, Zhou Z, Redfors B, Lindenfeld J, Abraham WT, Mack MJ, Stone GW, Bax JJ
Aims: The impact of mitral valve geometry on outcomes after MitraClip treatment in secondary mitral regurgitation (MR) has not been examined. We therefore sought to evaluate the association between mitral valve geometry and outcomes of patients with heart failure (HF) and secondary MR treated with guideline-directed medical therapy (GDMT) and MitraClip. Methods and results: Mitral valve geometry was assessed from the baseline echocardiograms in 614 patients from the COAPT trial. The primary endp... Abstract
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Volume 63, Issue 10, 1 1 2022, Pages 1455-1458 Integrating Nuclear Imaging and Cardiology in Clinical Practice: A Conversation Between Jeroen J. Bax and Frank M. Bengel. Bax JJ, Bengel FM
Cited 1 times since 2022 (0.4 per year) source: EuropePMC
Journal of global health, Volume 12, 1 1 2022, Pages 05042 Community-based SARS-CoV-2 testing in low-income neighbourhoods in Rotterdam: Results from a pilot study. Vink M, Iglói Z, Fanoy EB, van Beek J, Boelsums T, de Graaf M, Voeten HACM, Molenkamp R, Koopmans MP, Mevissen FE
Background: High incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and low testing uptake were reported in low-income neighbourhoods in Rotterdam. We aimed to improve willingness and access to testing by introducing community-based test facilities, and to evaluate the effectiveness of a rapid antigen detection test (RDT). Methods: Two to eleven test facilities operated consecutively in three low-income neighbourhoods in Rotterdam, offering the options of walk-in or appoin... Abstract
Cited 4 times since 2022 (1.7 per year) source: EuropePMC
Current protocols, Volume 2, Issue 10, 1 1 2022, Pages e564 Three-Dimensional Vessels-on-a-Chip Based on hiPSC-derived Vascular Endothelial and Smooth Muscle Cells. Bulut M, Vila Cuenca M, de Graaf M, van den Hil FE, Mummery CL, Orlova VV
Blood vessels are composed of endothelial cells (ECs) that form the inner vessel wall and mural cells that cover the ECs to mediate their stabilization. Crosstalk between ECs and VSMCs while the ECs undergo microfluidic flow is vital for the function and integrity of blood vessels. Here, we describe a protocol to generate three-dimensional (3D) engineered vessels-on-chip (VoCs) composed of vascular cells derived from human induced pluripotent stem cells (hiPSCs). We first describe protocols for... Abstract
Cited 3 times since 2022 (1.2 per year) source: EuropePMC
European journal of preventive cardiology, Volume 29, Issue 14, 1 1 2022, Pages 1842-1851 Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab. Landmesser U, McGinniss J, Steg PG, Bhatt DL, Bittner VA, Diaz R, Dilic M, Goodman SG, Jukema JW, Loy M, Pećin I, Pordy R, Poulsen SH, Szarek M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators
Aims: European guidelines set low-density lipoprotein cholesterol (LDL-C) treatment goals <1.4 mmol/L after acute coronary syndrome (ACS), and <1.0 mmol/L for patients with recurrent cardiovascular events ≤2 years. Many ACS patients do not achieve these goals on statin alone. We examined actual goal achievement with alirocumab and projected achievement with ezetimibe, either added to optimized statin therapy. Methods and results: The ODYSSEY OUTCOMES trial (NCT01663402) compared al... Abstract
Cited 682 times since 2022 (283.2 per year) source: EuropePMC
European heart journal, Volume 43, Issue 40, 1 1 2022, Pages 3997-4126 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M, ESC Scientific Document Group
Cited 2 times since 2022 (0.8 per year) source: EuropePMC
European heart journal. Cardiovascular Imaging, Volume 23, Issue 11, 1 1 2022, Pages 1457-1458 Using deep learning to diagnose pulmonary hypertension. van der Bijl P, Bax JJ
European heart journal, Volume 43, Issue 38, 1 1 2022, Pages 3599-3600 The mentorship programme: a new initiative at the European Heart Journal. Ajmone Marsan N, Cavalcante J, Bucciarelli-Ducci C
Cited 1 times since 2022 (0.4 per year) source: EuropePMC
PloS one, Volume 17, Issue 9, 30 5 2022, Pages e0274478 Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas. Bayley JP, Rebel HG, Scheurwater K, Duesman D, Zhang J, Schiavi F, Korpershoek E, Jansen JC, Schepers A, Devilee P
The neuroendocrine tumours paraganglioma and pheochromocytoma (PPGLs) are commonly associated with succinate dehydrogenase (SDH) gene variants, but no human SDH-related PPGL-derived cell line has been developed to date. The aim of this study was to systematically explore practical issues related to the classical 2D-culture of SDH-related human paragangliomas and pheochromocytomas, with the ultimate goal of identifying a viable tumour-derived cell line. PPGL tumour tissue/cells (chromaffin cells)... Abstract
Cited 154 times since 2022 (63.9 per year) source: EuropePMC
Nature, Volume 611, Issue 7934, 30 5 2022, Pages 115-123 Stroke genetics informs drug discovery and risk prediction across ancestries. Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, Kamanu FK, Koido M, Le Grand Q, Shi M, He Y, Georgakis MK, Caro I, Krebs K, Liaw YC, Vaura FC, Lin K, Winsvold BS, Srinivasasainagendra V, Parodi L, Bae HJ, Chauhan G, Chong MR, Tomppo L, Akinyemi R, Roshchupkin GV, Habib N, Jee YH, Thomassen JQ, Abedi V, Cárcel-Márquez J, Nygaard M, Leonard HL, Yang C, Yonova-Doing E, Knol MJ, Lewis AJ, Judy RL, Ago T, Amouyel P, Armstrong ND, Bakker MK, Bartz TM, Bennett DA, Bis JC, Bordes C, Børte S, Cain A, Ridker PM, Cho K, Chen Z, Cruchaga C, Cole JW, de Jager PL, de Cid R, Endres M, Ferreira LE, Geerlings MI, Gasca NC, Gudnason V, Hata J, He J, Heath AK, Ho YL, Havulinna AS, Hopewell JC, Hyacinth HI, Inouye M, Jacob MA, Jeon CE, Jern C, Kamouchi M, Keene KL, Kitazono T, Kittner SJ, Konuma T, Kumar A, Lacaze P, Launer LJ, Lee KJ, Lepik K, Li J, Li L, Manichaikul A, Markus HS, Marston NA, Meitinger T, Mitchell BD, Montellano FA, Morisaki T, Mosley TH, Nalls MA, Nordestgaard BG, O'Donnell MJ, Okada Y, Onland-M
Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-r... Abstract
Cited 8 times since 2022 (3.3 per year) source: EuropePMC
European journal of endocrinology, Volume 187, Issue 5, 30 5 2022, Pages S35-S46 Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies. Alwan H, Villoz F, Feller M, Dullaart RPF, Bakker SJL, Peeters RP, Kavousi M, Bauer DC, Cappola AR, Yeap BB, Walsh JP, Brown SJ, Ceresini G, Ferrucci L, Gussekloo J, Trompet S, Iacoviello M, Moon JH, Razvi S, Bensenor IM, Azizi F, Amouzegar A, Valdés S, Colomo N, Wareham NJ, Jukema JW, Westendorp RGJ, Kim KW, Rodondi N, Del Giovane C
Objective: Few prospective studies have assessed whether individuals with subclinical thyroid dysfunction are more likely to develop diabetes, with conflicting results. In this study, we conducted a systematic review of the literature and an individual participant data analysis of multiple prospective cohorts to investigate the association between subclinical thyroid dysfunction and incident diabetes. Methods: We performed a systematic review of the literature in Medline, Embase, and the Cochran... Abstract
Cited 3 times since 2022 (1.2 per year) source: EuropePMC
JACC. Clinical electrophysiology, Volume 8, Issue 10, 28 4 2022, Pages 1234-1245 Ventricular Arrhythmia Substrate Distribution and Its Relation to Sympathetic Innervation in Nonischemic Cardiomyopathy Patients. Chen HS, Jungen C, Kimura Y, Dibbets-Schneider P, Piers SR, Androulakis AFA, van der Geest RJ, de Geus-Oei LF, Scholte AJHA, Lamb HJ, Jongbloed MRM, Zeppenfeld K
Background: Nonischemic cardiomyopathy patients referred for catheter ablation of ventricular arrhythmias (VAs) typically have either inferolateral (ILS) or anteroseptal (ASS) VA substrate locations, with poorer outcomes for ASS. Sympathetic denervation is an important determinant of arrhythmogenicity. Its relation to nonischemic fibrosis in general and to the different VA substrates is unknown. Objectives: This study sought to evaluate the association between VA substrates, myocardial fibrosis,... Abstract
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, Volume 36, Issue 1, 27 4 2022, Pages 128-129 Response to "Why Are Bicuspid Aortic Valve Patients Flying Under the Radar?" Stassen J, Bax JJ
Cited 1 times since 2022 (0.4 per year) source: EuropePMC
Journal of cardiopulmonary rehabilitation and prevention, Volume 42, Issue 6, 24 4 2022, Pages E99-E100 Know Your Numbers: Patient and Physician Disparity in Cardiovascular Risk Perception After an Acute Coronary Syndrome. Ter Hoeve N, Jorstad HT, Sunamura M, Janssen VR, Scholte Op Reimer WJM, Snaterse M
Cited 2 times since 2022 (0.8 per year) source: EuropePMC
The American journal of cardiology, Volume 184, 23 4 2022, Pages 63-71 Impact of Worsening Heart Failure on Long-Term Prognosis in Patients With Heart Failure With Reduced Ejection Fraction. Chimed S, Stassen J, Galloo X, Meucci MC, van der Bijl P, Knuuti J, Delgado V, Marsan NA, Bax JJ
Worsening heart failure (HF), defined as hospitalization for worsening signs and symptoms of HF or the need for urgent intravenous diuretics, is often considered a surrogate of poor prognosis in clinical trials. However, data on the prognostic implications of worsening HF in patients with HF and reduced ejection fraction is limited. Patients who had a first echocardiographic diagnosis of left ventricular systolic dysfunction, defined as left ventricular ejection fraction (LVEF) ≤45%, were identi... Abstract
Cited 8 times since 2022 (3.3 per year) source: EuropePMC
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Volume 62, 23 4 2022, Pages 107478 Structural abnormalities in the non-dilated ascending aortic wall of bicuspid aortic valve patients. Grewal N, Girdauskas E, Idhrees M, Velayudhan B, Klautz R, Driessen A, Poelmann RE
Background: A bicuspid aortic valve (BAV) is the most common congenital cardiac malformation. The development of the aortic valve is closely related to the development of the ascending aorta, associated with structural differences in the bicuspid aorta. Here we describe the non-dilated ascending aortic wall in bicuspid aortic valve patients. Methods: BAV (n=41) and tricuspid aortic valve (TAV) (n=18) non-dilated ascending aortic wall samples were studied. We investigated the following features o... Abstract